2Mulholland J W. The Great Britain and Ireland perspective: current perfusion safety issues, preparing for the future[J]. Perfusion, 2005,20 : 217-225.
3Ege T,Arar C,Canbaz S,Cikirikcioglu M,Sunar H, Yuksel V, et al. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery[J].Thorac Cardiovasc Surg, 2004,52 : 10-15.
4Sugita T, Watarida S, Katsuyama K, Nakajima Y, Yamamoto R,Mori A. Effect of a human urinary protease inhibitor (Ulinastatin) on respiratory function in pediatric patients undergo ing cardiopulmonary bypass[J]. J Cardivasc Surg(Torino), 2002,43:437-440.
5Wenbin L,Jianqun Z, Qiwen Z, Baotian C, Xiufang X, Zhaoguang Z, et al. Surgical treatment of mitral regurgitation associated with enlarged left ventricle[J]. J Heart Valve Dis,2002, 23:181- 184.
6Lango R,Pawlaczyk R,Raszeja Specht A,Smolenski RT,Rogowski J,Rutkowski B, et al. Aortic valve replacement and perioperative management in hemodialyzed patient with antiphospholipid syndrome[J].Int J Artif Organs,2004,27: 69-73.
7De Santo L S,Romano G,Della Corte A,Tizzano F,Petraio A, Amarelli C, et al. Mitral mechanical replacement in young rheumatic women: analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707 -patient-year follow up[J]. J Thorac Cardiovasc Surg,2005,130:13-19.
8Vaquette B,Corbineau H, Laurent M, Lelong B, Langanay T, de Place C,et al. Valve replacement in patients with critical aortic stenosis and depressed left ventricular function: predictors of operative risk, left ventricular function recovery, and long term outcome[J]. Heart,2005,91:1324 -1329.
9Sane S,Baha M,Kusamo C,Shirao K,Yamada H,Aikou T. Relation between effective utilization of exogenous fat emulsion as energy substrate and oxygen metabolism after surgery [J]. Word J Surg,2000,24: 1542-1549.
